Casdin Capital, LLC

Casdin Capital, LLC reported 48 holdings worth US$2.3B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Casdin Capital, LLC reported 48 holdings worth US$2.3B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Relay Therapeutics, Inc. and GeneDx Holdings Corp. Filed Nov 16, 2026 (Form 13F).

Holdings
48
Value as reported
US$2.3B

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.2.58MUS$529M23.0%
Relay Therapeutics, Inc.16MUS$289M12.6%
GeneDx Holdings Corp.3.71MUS$268M11.7%
BioLife Solutions, Inc.4.5MUS$175M7.6%
Illumina, Inc.530KUS$145M6.3%
GRAIL, Inc.680KUS$95.3M4.2%
10x Genomics, Inc.1.05MUS$94.9M4.1%
Standard BioTools Inc.88.8MUS$65.8M2.9%
Neurogene Inc.1.59MUS$44.1M1.9%
Scholar Rock Holding Corporation850KUS$41.1M1.8%
Personalis, Inc.2.3MUS$37.4M1.6%
Beam Therapeutics Inc.1.5MUS$36.7M1.6%
Tempus AI, Inc.424KUS$34.7M1.5%
Sarepta Therapeutics, Inc.1.82MUS$33.2M1.4%
Guardant Health, Inc.185KUS$33M1.4%
Structure Therapeutics, Inc.1.03MUS$32.2M1.4%
Alnylam Pharmaceuticals, Inc.120KUS$29.6M1.3%
Denali Therapeutics Inc.1.25MUS$25.8M1.1%
Hims & Hers Health, Inc.800KUS$23.8M1.0%
Maze Therapeutics, Inc.844KUS$22.9M1.00%
Septerna, Inc.553KUS$21.6M0.94%
Parabilis Medicines, Inc.646KUS$20.8M0.91%
Adlai Nortye Group Ltd.1.25MUS$20M0.87%
Taysha Gene Therapies, Inc.3.9MUS$19M0.83%
AgomAb Therapeutics NV1.55MUS$17.2M0.75%
ORIC Pharmaceuticals, Inc.1.25MUS$16.8M0.73%
Moderna, Inc.75,000US$14.4M0.63%
Veracyte, Inc.276KUS$12.7M0.55%
Quest Diagnostics Incorporated50,000US$11.7M0.51%
Biogen Inc.50,000US$11.3M0.49%
Edgewise Therapeutics, Inc.265KUS$10.8M0.47%
Absci Corporation973KUS$10.5M0.46%
Prime Medicine, Inc.3.17MUS$9.68M0.42%
BioNTech SE85,000US$8.36M0.36%
Braveheart Bio, Inc.400KUS$8.08M0.35%
Rapport Therapeutics, Inc.200KUS$6.72M0.29%
Intellia Therapeutics, Inc.355KUS$4.28M0.19%
Century Therapeutics, Inc.1.23MUS$2.1M0.09%
Contineum Therapeutics, Inc.148KUS$1.99M0.09%
Pacific Biosciences of California, Inc.724KUS$1.72M0.07%
BridgeBio Oncology Therapeutics, Inc.282KUS$1.16M0.05%
Editas Medicine, Inc.445KUS$1.14M0.05%
Monte Rosa Therapeutics, Inc.86,014US$1.03M0.04%
Kardigan, Inc.50,000US$738K0.03%
Recursion Pharmaceuticals, Inc.165KUS$683K0.03%
Ginkgo Bioworks Holdings, Inc.36,493US$468K0.02%
Tenaya Therapeutics, Inc.362KUS$218K<0.01%
Disc Medicine, Inc.0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related